Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £16.31m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Directorate Change

17 Dec 2021 07:00

RNS Number : 9380V
Mission Group PLC (The)
17 December 2021
 

17 December 2021

THE MISSION GROUP plc

 

("MISSION", "the Group") 

 

Appointment of Non-Executive Director

The MISSION Group plc (AIM: TMG), creator of Work That Counts comprising a network of 16 Agencies delivering real, sustainable growth for its Clients, is pleased to announce that is has appointed Dr Eliza Filby as a Non-Executive Director, effective 1 January 2022.

Dr Eliza Filby is a 'Generational Intelligence' expert with a longstanding career in helping businesses understand generational shifts within politics, society and the workplace. Her experience involves consulting with a large range of companies and organisations including Warner Brothers, HSBC, the Ministry of Defence and the Royal Household.

 

Dr Filby will replace Non-Executive Director Andrew Nash as Chair of the Company's Remuneration Committee on appointment. Andrew will take over the role Senior Independent Director and will Chair MISSION's Audit and Risk Committee.

James Clifton, Chief Executive of The MISSION Group plc, commented: "We are very excited to have Dr Filby on board. She has unique specialist expertise on generational differences and trends, which is highly relevant and valuable to much of the work MISSION does for Clients seeking to better understand their consumers. As well as extensive experience advising blue-chip corporates and government bodies, Dr Filby is a regular speaker at major business events such as the Financial Times CEO Forum. A published author, Dr Filby has also led and authored several reports and projects into the future of workplace dynamics and demographic trends."

 

Dr Eliza Filby added: "I am thrilled to be joining The MISSION Group and working with James and the team. It is a fantastic business and I look forward to supporting it through its future growth journey."

 

ENQUIRIES:

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

 

020 7462 1415

 

 

Mark Percy / James Thomas / Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

 

 

 

Kate Hoare / Laura Stewart

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

NOTES TO EDITORS

 

MISSION is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit. Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to produce Work That Counts for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands. www.themission.co.uk

 

Regulatory disclosures (in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies)

Save for the information set out above and below, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Dr Elizabeth Rosana Filby, aged 40.

Dr Filby holds the following current directorships

Eliza Filby Associates Ltd

Filbyproductions Ltd

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEQLFFFLLBFBL
Date   Source Headline
16th May 202410:29 amRNSForm 8.3 - Mission Group PLC
16th May 20248:25 amRNSForm 8.5 (EPT/RI)
15th May 20241:46 pmRNSHolding(s) in Company
15th May 202412:47 pmRNSForm 8.3 - Mission Group Plc
15th May 202412:07 pmRNSForm 8.3 - The Mission Group plc
15th May 202411:32 amRNSForm 8.5 (EPT/NON-RI) - Replacement
15th May 202411:27 amRNSForm 8.3
15th May 202411:16 amRNSForm 8.5 (EPT/RI)
15th May 202411:00 amRNSForm 8.5 (EPT/NON-RI)
15th May 20247:00 amRNSResponse re possible offer for The MISSION Group
14th May 20245:10 pmRNSForm 8.3 - Mission Group Plc
14th May 20242:55 pmRNSForm 8.3 - Mission Group PLC
14th May 20242:21 pmGNWForm 8.3 - The Mission Group plc
14th May 20242:06 pmRNSForm 8.3
14th May 20241:42 pmRNSForm 8.3 - Mission Group Plc
14th May 202412:21 pmRNSForm 8.3 - Mission Group PLC/Brave Bison Group PLC
14th May 202410:39 amRNSForm 8.3 - The Mission Group PLC
14th May 20249:57 amRNSForm 8.5 (EPT/NON-RI)
13th May 20244:18 pmGNWForm 8.3 - The Mission Group plc
13th May 20247:00 amRNSResponse to Press Speculation & Possible Offer
13th May 20247:00 amRNSPossible All Share Offer for The Mission Group plc
2nd May 20244:12 pmRNSHolding(s) in Company
18th Apr 202410:00 amRNSIssue of Contingent Consideration Shares & TVR
2nd Apr 20247:00 amRNSFinal Results
28th Mar 20245:30 pmRNSFinal Results
17th Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDISPOSAL UPDATE - PATHFINDR
20th Dec 20237:34 amRNSTrading Statement
24th Nov 202312:46 pmRNSBoard Change
7th Nov 20232:47 pmRNSNotification of Major Holdings
31st Oct 20235:07 pmRNSHolding(s) in Company
31st Oct 20239:29 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSTRADING UPDATE AND REVISED OUTLOOK FOR 2023
19th Oct 20236:25 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2023
25th Sep 202310:27 amRNSNEW CONTRACT WIN
20th Sep 20239:44 amRNSInvestor Presentation
27th Jul 20237:01 amRNSTrading Update
27th Jul 20237:00 amRNSChange of Adviser
20th Jun 20232:44 pmRNSResult of AGM
20th Jun 20237:00 amRNSDirector Dealing
3rd Apr 20237:00 amRNSDividend Declaration
28th Mar 20237:00 amRNSFinal Results
24th Mar 20237:00 amRNSInvestor Presentation
16th Mar 202310:16 amRNSLaunch Of New Integrated Growth Media Agency
14th Feb 20237:00 amRNSACQUISITION OF MEZZO LABS
12th Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSACQUISITION OF INFLUENCE SPORTS & MEDIA
31st Oct 20224:39 pmRNSHolding(s) in Company
27th Sep 20227:01 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.